BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 28560754)

  • 1. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
    Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
    J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons.
    Dang W; Xu L; Yin Y; Chen S; Wang W; Hakim MS; Chang KO; Peppelenbosch MP; Pan Q
    Antiviral Res; 2018 Jul; 155():48-59. PubMed ID: 29753657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.
    Shu XS; Zhao Y; Sun Y; Zhong L; Cheng Y; Zhang Y; Ning K; Tao Q; Wang Y; Ying Y
    J Pathol; 2018 Jan; 244(1):36-48. PubMed ID: 28940253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between different family members: IL27 recapitulates IFNγ responses in HCC cells, but is inhibited by IL6-type cytokines.
    Rolvering C; Zimmer AD; Kozar I; Hermanns HM; Letellier E; Vallar L; Nazarov PV; Nicot N; Ginolhac A; Haan S; Behrmann I; Haan C
    Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):516-526. PubMed ID: 27939431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.
    Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y
    Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin.
    Gunaje JJ; Bhat GJ
    Biochem Biophys Res Commun; 2001 Oct; 288(1):252-7. PubMed ID: 11594781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
    Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
    J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.
    Min YQ; Ning YJ; Wang H; Deng F
    J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
    J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
    Wu S; Lin J; Fu Y; Ou Q
    Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive pro-inflammatory gene signatures induced in articular chondrocytes by oncostatin M and IL-6 are regulated by Suppressor of Cytokine Signaling-3.
    Liu X; Liu R; Croker BA; Lawlor KE; Smyth GK; Wicks IP
    Osteoarthritis Cartilage; 2015 Oct; 23(10):1743-54. PubMed ID: 26045176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection.
    Zhao Y; Ye X; Dunker W; Song Y; Karijolich J
    Nat Commun; 2018 Nov; 9(1):4841. PubMed ID: 30451863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
    Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
    Front Immunol; 2019; 10():1164. PubMed ID: 31191537
    [No Abstract]   [Full Text] [Related]  

  • 19. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.
    Esser-Nobis K; Hatfield LD; Gale M
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
    Liu X; Sadaoka T; Krogmann T; Cohen JI
    J Virol; 2020 May; 94(11):. PubMed ID: 32213613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.